Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Oxford Immunotec Global PLC | oxfd20140315_10k.htm |
| EX-10 - EXHIBIT 10.20 - Oxford Immunotec Global PLC | ex10-20.htm |
| EX-4 - EXHIBIT 4.3 - Oxford Immunotec Global PLC | ex4-3.htm |
| EX-4 - EXHIBIT 4.4 - Oxford Immunotec Global PLC | ex4-4.htm |
| EX-10 - EXHIBIT 10.45 - Oxford Immunotec Global PLC | ex10-45.htm |
| EX-31 - EXHIBIT 31.2 - Oxford Immunotec Global PLC | ex31-2.htm |
| EX-4 - EXHIBIT 4.2 - Oxford Immunotec Global PLC | ex4-2.htm |
| EX-10 - EXHIBIT 10.4 - Oxford Immunotec Global PLC | ex10-4.htm |
| EX-32 - EXHIBIT 32 - Oxford Immunotec Global PLC | ex32.htm |
| EX-31 - EXHIBIT 31.1 - Oxford Immunotec Global PLC | ex31-1.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-192582) pertaining to the Amended and Restated 2008 Stock Incentive Plan of Oxford Immunotec Global PLC and Registration Statement (Form S-8 No. 333-193730) pertaining to the Oxford Immunotec Global PLC 2013 Share Incentive Plan of our report dated March 27, 2014 with respect to the consolidated financial statements of Oxford Immunotec Global PLC included in this Annual Report (Form 10-K) for the year ended December 31, 2013.
/s/ Ernst & Young LLP
Reading, United Kingdom
March 27, 2014